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Macrophage Control of Mycobacterial Growth Induced by
Picolinic Acid Is Dependent on Host Cell Apoptosis1
Teresa F. Pais and Rui Appelberg2
The effects of picolinic acid (PA) on the intramacrophagic growth of Mycobacterium avium were studied. PA reduced M. avium
growth inside mouse macrophages and led to a complete control of mycobacterial growth when added together with IFN-g. The
mechanism involved did not require TNF-a, NO, or the respiratory burst, and was not dependent on either iron or zinc with-
holding. The mycobacteriostatic activity of the macrophages was associated with the induction of morphological changes that
culminated in apoptosis at day 4 of treatment. PA alone induced apoptosis in macrophages, and this effect was increased by IFN-g
treatment. Apoptosis at day 4 of infection was reduced by inhibiting macrophage activation with the prostaglandin 15 deoxy-
prostaglandin J2 or by treating the cells with the antioxidant N-acetylcysteine. Mycobacterial growth was partially restored in
macrophages treated with PA and IFN-g when 15 deoxy-prostaglandin J2 was added, concomitant with a delay in apoptosis.
N-Acetylcysteine or glutathione could also completely revert the mycobacteriostatic effects of PA or PA plus IFN-g. The Journal
of Immunology, 2000, 164: 389–397.
Mycobacterium avium is an intracellular facultative bac-terium that proliferates inside host macrophages (1).Upon activation by cytokines such as IFN-g and/or
TNF-a, mouse macrophages can cause a limited restriction of the
growth of M. avium through a mechanism that is neither dependent
on NO (2) or on reactive oxygen intermediates (3, 4), but which
may involve iron deprivation (5, 6). In contrast, many researchers
have failed to find such a protective effect of IFN-g when studying
M. avium infections in cultured human monocytes (7, 8), despite
clinical evidence for a major role of IL-12/IFN-g pathways in the
control of infections by mycobacteria in humans (9). We have
previously reported that, in addition to IFN-g/TNF-a activation,
there may be additional signals required to lead to complete con-
trol of M. avium infection in mice (10). It is therefore important to
study the role of other potential inducers of macrophage antimy-
cobacterial mechanisms.
Several studies have shown an involvement of tryptophan ca-
tabolism in the antimicrobial mechanisms of the macrophage. Dur-
ing the in vitro activation of human fibroblast and monocytes with
IFN-g, the depletion of tryptophan due to the induction of 2,3-
indoleamine dioxygenase is partially responsible for the inhibition
of intracellular growth of Toxoplasma gondii (11–15), Leishmania
donovani (12), Legionella pneumophila (16), Chlamydia spp. (12–
14, 17), or CMV (18). Depletion of tryptophan should not affect
the intracellular growth of M. avium because mycobacteria are able
to synthesize all of the amino acids required for growth (19). The
induction of tryptophan catabolism has been reported in patients
with cancer (20), in mice infected with influenza virus (21), in
AIDS patients (22), and in humans infected with Mycobacterium
tuberculosis and Salmonella (23). However, the possible role of
the catabolites of tryptophan metabolism as part of the antimicro-
bial responses has never been seriously considered in those studies.
Picolinic acid (PA)3 is one of the naturally occurring degradation
products of tryptophan. This molecule is able to form stable com-
plexes with transition metal ions (24), and its chelating properties
seem to facilitate the absorption of zinc from the intestine (25) and
explain the inhibitory effect of PA in the axenic growth of Esch-
erichia coli (26) as well as in the growth of normal kidney rat cells
(27, 28). PA is also tumoricidal in vivo (29), an effect that is related
to the induction of macrophage-mediated cytostatic activity (30).
The idea that PA plays a role in immune mechanisms is strength-
ened by the observation that mice treated with PA have enhanced
levels of mRNA for IL-1 and TNF-a and higher resistance to Can-
dida albicans (31). In vitro studies with macrophages confirmed
that PA is a modulator of macrophage functions because it co-
stimulates macrophage activation and enhances the antitumor ac-
tivity of peritoneal macrophages treated with IFN-g (32). In this
work, we have assessed the ability of PA to modulate anti-M.
avium mechanisms in cultured mouse macrophages. We show that
administration of PA to macrophages infected with M. avium in-
duced mycobacterial growth inhibition strongly synergizing with
IFN-g in the induction of complete mycobacteriostasis.
Materials and Methods
Mycobacteria
A smooth transparent (SmT) variant of M. avium strain 25291 was obtained
from the American Type Culture Collection (Manassas, VA). Strain 2-151
SmT and GIR10 SmT were given by J. Belisle (Colorado State University,
Fort Collins, CO) and B. Heym (Institut Pasteur, Paris, France), respec-
tively. The mycobacteria were grown in Middlebrook 7H9 broth (Difco,
Detroit, MI) containing 10% albumin/dextrose/catalase (ADC) supplement
(Difco) and 0.04% Tween 80 (Sigma, St. Louis, MO) at 37°C until mid-log
phase. The bacteria were collected by centrifugation, washed in saline con-
taining 0.04% Tween 80, and then resuspended in a small volume of the
same solution. The suspension was briefly sonicated until no bacterial
Laboratory of Microbiology and Immunology of Infection, Institute for Molecular and
Cell Biology, University of Porto, Porto, Portugal
Received for publication July 12, 1999. Accepted for publication October 14, 1999.
The costs of publication of this article were defrayed in part by the payment of page
charges. This article must therefore be hereby marked advertisement in accordance
with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by Contract P/SAU58/96 from the PRAXIS XXI Pro-
gramme (Lisbon). T.F.P. received a fellowship from the PRAXIS XXI Programme.
2 Address correspondence and reprint requests to Dr. Rui Appelberg, Laboratory of
Microbiology and Immunology of Infection, Institute for Molecular and Cell Biology,
Rua do Campo Alegre 823, 4150-171 Porto, Portugal. E-mail address: rappelb@
ibmc.up.pt
3 Abbreviations used in this paper: PA, picolinic acid; 15d-PGJ2, 15 deoxy-prosta-
glandin J2; iNOS, inducible NO synthase; NAC, N-acetylcysteine; PPAR-g, peroxi-
some proliferator-activated receptor-g; SmT, smooth transparent; SOD, superoxide
dismutase.
Copyright © 2000 by The American Association of Immunologists 0022-1767/00/$02.00
clumps were visualized by optical microscopy. The preparation was diluted
and frozen in aliquots at 270°C. The aliquots were thawed at 37°C and
diluted to the desired concentration before inoculation, according to a pre-
vious quantification. For determining numbers of viable mycobacteria, se-
rial dilutions of the suspensions were plated on solid Middlebrook 7H10
agar medium (Difco) supplemented with 10% OADC (5% BSA, 0.06%
oleic acid, and 2% dextrose).
Cell cultures
Bone marrow-derived macrophages were obtained by cultivating bone
marrow cells from BALB/c or C57BL/6 mice, obtained by flushing the
femurs with HBSS (Life Technologies, Paisley, U.K.). In some experi-
ments, mice genetically deficient in the genes for the inducible NO syn-
thase (iNOS2/2, in a C57BL/6 background), the TNF receptor p55
(p552/2, in a C57BL/6 background), or the p47phox protein (p47phox2/2, in
a mixed 129 3 C57BL/6 background) were used. To remove fibroblasts,
the cells were cultured overnight on cell culture dishes with DMEM (Life
Technologies) supplemented with 10 mM HEPES, 1 mM sodium pyruvate,
10 mM glutamine, 10% of heat-inactivated Myoclone calf serum (Life
Technologies), and 10% of L929 cell-conditioned medium. The nonadher-
ent cells were collected with warm HBSS medium and culture for 9 days
with L929 cell-conditioned medium until they were completely differen-
tiated, as previously described (3). Peritoneal macrophages were obtained
from C57BL/6 mice by injecting them i.p. with 1 ml of 4% of thioglyco-
late. The peritoneal exudate was collected 4 days later by washing the
peritoneal cavity with 10 ml of HBSS. The cells were resuspended at the
concentration of 2–3 3 106 cells/ml in complete DMEM and cultured for
2 h for cells to adhere. Then the cells were washed with warm HBSS, and
the remaining adherent cells were infected. When necessary, the number of
macrophages was determined by lysing the cells with 3% cetrimide (Sig-
ma) and 0.25% Pronase (Sigma) and counting the nuclei in a
hemocytometer.
Studies in axenic medium
A total of 5 3 105 CFU/ml of M. avium strains 25291 SmT, GIR10 SmT,
and 2-151 SmT was inoculated in DMEM or in DMEM plus PA (2, 4, 8,
16, 32 mM). The mycobacteria were cultured in 24-well plates at 37°C in
a CO2 incubator. Saponin was added to the wells at day 6 to a final con-
centration of 0.1%, and the cultures were briefly sonicated to disrupt the
clumps before serial dilution and plating on Middlebrook 7H10 medium.
Infection of macrophages and inhibition studies
Each well containing ;0.5 3 106 macrophages was infected with 0.2 ml
of DMEM containing 1–5 3 106 CFU of M. avium for 4 h. After infection,
the cultures were washed with HBSS to remove unphagocytosed bacteria.
Macrophages from triplicate wells (time 0) were immediately lysed in
0.1% saponin, and serial dilutions were plated in 7H10 solid medium. To
test the anti-M. avium activity of PA (Sigma), bone marrow-derived mac-
rophages were treated daily after infection with 2 mM PA, 100 U/ml IFN-g
(R&D Systems, Minneapolis, MN) or PA (2 mM) plus IFN-g (100 U/ml)
until day 3 of infection. Ferric citrate, iron sulfate, zinc sulfate (Merck,
Darmstadt, Germany), apotransferrin (Sigma), IL-4 (R&D), and anti-TNF
mAbs (clone MP6-XT22; DNAX, Palo Alto, CA) were added after infec-
tion, where indicated. Catalase (bovine or erythrocyte; Sigma or Calbio-
chem, San Diego, CA) or superoxide dismutase (SOD; Sigma or Calbio-
chem) was added during phagocytosis and after washing the extracellular
bacteria in the indicated experiments. N-Acetylcysteine (NAC; Sigma) or
glutathione (Sigma) was added to macrophages during infection (10 mM),
1 h after infection at a final concentration of 50 mM, washed away, and
then added at days 0 and 1 at a final concentration of 5 mM, where indi-
cated. In the experiments with peritoneal macrophages, IFN-g (100 U/ml)
was added at days 0 and 1, and PA (2 mM) was added until day 3 of
infection. The prostaglandin 15d-PGJ2 (Cayman Chemical, Ann Arbor,
MI) was added after infection at a final concentration of 6 mM. The my-
cobacterial growth was monitored by lysing macrophages in triplicate
wells up to day 6 of infection. The results are expressed as CFU 6 1 SD
of the means.
Electron microscopy
Macrophages infected with M. avium strain 25291 SmT were processed for
electron microscopy at day 4 of infection. Macrophages were fixed for 1 h
at room temperature with 2.5% glutaraldehyde in 0.1 M cacodylate buffer
containing 0.1 M sucrose, 5 mM Ca21, and 5 mM Mg21, pH 7.2. The cells
were scraped off the culture dishes with a rubber policeman and treated
with 1% osmium tetroxide. Postfixation was done in 1% uranyl acetate.
After dehydration in ethanol, the samples were embedded in Epon. Sec-
tions were stained with uranyl acetate and lead citrate.
Analysis and quantification of apoptosis
Apoptosis was studied with different assays. For the use of the annexin
V-FITC staining, macrophages were cultured on petri dishes and infected
with M. avium strain 25291 SmT. At day 4 of infection, nonadherent cells
were collected by aspiration of the medium and adherent macrophages
were detached by incubating the dishes with cold PBS containing 0.5 mM
EDTA during 1 h. Cells were pooled and washed once with binding buffer
(10 mM HEPES buffer containing 0.14 mM NaCl and 2.5 mM CaCl2, pH
7.4). A total of 2–5 3 105 cells was incubated in 100 ml of binding buffer
containing 2.5 ml of annexin V-FITC (PharMingen, San Diego, CA) for 20
min in ice. Propidium iodide (1 mg/ml) was added before analysis on a
FACSorter flow cytometer (Becton Dickinson, Mountain View, CA) to
exclude mechanically damaged cells. To evaluate apoptosis by staining
DNA with propidium iodide, macrophages were obtained as described
above and were permeated with 70% ethanol for 10 min. After centrifu-
gation, the cells were stained for 20 min at 37°C with 50 mg/ml propidium
iodide in PBS containing 100 mg/ml RNase (Boehringer Mannheim, Ott-
weiler, Germany). Cells were analyzed for propidium iodide fluorescence
(DNA content) by FACS. To perform DNA labeling with fluorescein
dUTP, macrophages were stained with the APO-DIRECT kit, according to
the manufacturer’s instructions (Phoenix Flow Systems, San Diego, CA).
Finally, cellular viability was also studied by looking at the mitochondrial-
dependent reduction of MTT to formazan, as described before (33). Briefly,
macrophages were incubated with MTT (0.25 mg/ml) for 1 h at 37°C, and
the formazan was dissolved with DMSO (Merck). The extent of reduction
of MTT to formazan was determined by measuring the OD at 550 nm.
Results
PA inhibits the intramacrophagic growth of M. avium and
synergizes with IFN-g in controlling mycobacterial proliferation
We tested the ability of PA to enhance the anti-M. avium activity
of IFN-g in bone marrow-derived macrophages from BALB/c
mice. Macrophages were infected with the virulent M. avium strain
25291SmT and treated after phagocytosis with PA (2 mM), IFN-g
(100 U/ml), or PA plus IFN-g daily during the first 3 days of
infection. The addition of PA alone to the infected macrophages
inhibited the intramacrophagic growth of M. avium measured by
CFU (Fig. 1). This decrease was already significant at day 4 of
infection ( p , 0.05). When PA was added together with IFN-g,
mycobacterial proliferation was completely controlled, as no sig-
nificant increase ( p . 0.05) in bacterial numbers was observed
during the 6 days of infection. The same bacteriostatic effect was
seen in freshly explanted peritoneal macrophages elicited with ei-
ther casein or thioglycolate (results not shown). The induction of
macrophage antimycobacterial activity by PA was also observed
with two additional strains of M. avium (Fig. 1). The effects of PA
on the intramacrophagic growth were independent of the sensitiv-
ity of the different strains to PA in axenic medium. Thus, although
M. avium strain Gir 10 grew 1 log in axenic medium containing 32
mM PA and was 4 times more resistant to PA in axenic medium
(IC50 5 4 mM) than strains 25291 SmT or 2-151 SmT (IC50 5 1
mM), the intramacrophagic growth at day 4 of strain Gir10 was
reduced by both PA (from 0.37 log to 0.11 log) or PA plus IFN-g
(from 0.37 log to 20.04 log) to similar extents as observed with
the two other strains: from 0.52 log to 0.20 log with PA and from
0.52 log to 0.05 log with PA plus IFN-g for strain 2-151 SmT, and
from 0.35 log to 0.24 log with PA and from 0.35 log to 0.07 log
with PA plus IFN-g for strain 25291 SmT, in the same experiment.
The effect of PA in the intramacrophagic growth of M. avium is
not dependent on commonly described bactericidal mechanisms
The arrest of normal rat kidney cell growth by PA (27, 28) is
abolished by the addition of either Zn21 or Fe31 (28) because PA
interferes with the intracellular levels of these metal ions (27). On
the other hand, it has been shown that iron is crucial for M. avium
growth (5, 6). Therefore, we tested whether the effects of PA or PA
390 MYCOBACTERIOSTASIS INDUCED BY PA
plus IFN-g could be blocked by supplementation of the culture
media with excess amounts of these ions. As shown in Fig. 2, the
anti-M. avium mechanism induced by PA was not due to the che-
lation of Fe or Zn21 ions, as the addition of either zinc sulfate or
iron in two different ionic forms (II or III) did not affect the growth
inhibition induced by PA. It is also unlikely that PA acted to pre-
vent binding of iron to transferrin, as an excess of apotransferrin
did not revert PA growth inhibition (Fig. 2A). Because the antitu-
mor costimulatory effect of PA is associated with the enhancement
of iNOS activity and with increased levels of TNF-a mRNA ex-
pression (34), we investigated the role of NO and of TNF-a in the
PA antimycobacterial mechanism. We found that there was no
difference in M. avium growth inhibition when bone marrow-de-
rived macrophages from iNOS gene-disrupted mice or TNF recep-
tor p55 gene-disrupted mice were used in the experiments and
compared with the respective control macrophages derived from
mice with similar background (C57BL/6, Fig. 3). In addition, the
neutralization of TNF-a with a mAb did not affect the intramac-
rophagic growth inhibition in macrophages treated with PA or PA
plus IFN-g (Fig. 2). Treatment with IL-4, which inhibits the co-
stimulatory tumoricidal activity of PA (35), did not revert its bac-
teriostatic effect (Fig. 2). Finally, the addition of catalase or SOD
plus catalase did not interfere with PA bacteriostatic activity (Fig.
2), showing that function of the NADPH oxidase is probably not
required for the effects of PA. This result was confirmed by using
bone marrow-derived macrophages from p47phox2/2 mice (Fig. 3),
which showed the same ability of wild-type macrophages (from
either the C57BL/6 or the 129 strains, although the latter data are
not shown) to restrict growth of M. avium after stimulation with
PA 6 IFN-g.
PA antimycobacterial activity occurs concomitantly with the
induction of apoptosis in treated macrophages
We observed that after 3 days of infection, the number of adherent
macrophages, measured by the Pronase-cetrimide method as well
as by the reduction of MTT, decreased when the cultures were
treated with PA plus IFN-g (results not shown). PA also induced
changes in cell morphology. At day 4 of infection, PA-treated
macrophages showed numerous small electron-transparent vacu-
oles in the cytoplasm (Fig. 4B) when compared with nontreated
cells (Fig. 4A), and at day 6 of infection there was extensive bleb-
bing of the treated cells, which became fragmented into small ves-
icles (Fig. 4D), whereas nontreated infected cells had a normal
appearance (Fig. 4C). As these changes were morphologically
compatible with apoptotic modifications, we measured by FACS
analysis the number of apoptotic cells by assessing, as a marker of
an early stage of apoptosis (36), the exposure of phosphatidylser-
ine at the outer leaflet of the plasma membrane at day 4 (Fig. 5A)
and, as a marker of a later stage, the fragmentation of DNA by
propidium iodide staining (37) at day 6 (Fig. 5B). Macrophages
treated with PA plus IFN-g showed clear signs of apoptosis al-
ready at day 4 with an increased exposure of phosphatidylserine
(29.9% 6 6 of positive cells) when compared with IFN-g-treated
(4.8% 6 0.8), PA-treated (6.9% 6 3.6), or nontreated cells (1.18%
6 0.2). At day 6, the highest percentage of cells with fragmented
DNA was seen in macrophages treated with PA plus IFN-g (58%).
PA alone was also able to induce DNA fragmentation, with 18%
of the cells showing hypoploid DNA when compared with IFN-
g-treated or nontreated cells. These results were further confirmed
by labeling DNA fragments with fluorescein dUTP (results not
shown).
The inhibition of apoptosis increases bacterial numbers in PA-
treated macrophages
Data presented to date suggest that the effects of PA on M. avium
were mediated through the macrophage, by modulating its func-
tion. However, they cannot formally exclude a direct effect of PA
on the mycobacteria. We therefore tested the effects of either a
deactivator of the macrophage, 15d-PGJ2 (38, 39), or an inhibitor
of apoptosis, NAC (39–42). Peritoneal macrophages elicited with
thioglycolate, known to express the peroxisome proliferator-acti-
vated receptor-g (PPAR-g) and to respond to 15d-PGJ2 (39), were
infected with M. avium 25291 SmT and stimulated with IFN-g
(100 U/ml, at days 0 and 1), with PA (2 mM daily), or with PA
plus IFN-g. As an indicator of macrophage activation, we analyzed
the levels of nitrites in the supernatants from the macrophage cul-
tures. When cells were treated with IFN-g or PA plus IFN-g in the
presence of 6 mM 15d-PGJ2, there was no activation of macro-
phages because nitrites were not detectable in the cultures (results
not shown). Macrophages treated with PA plus IFN-g in the pres-
ence of 15d-PGJ2 did not show the morphological changes seen in
macrophages treated with PA plus IFN-g in the absence of the
FIGURE 1. Complete restriction of growth of three isolates of M. avium is induced by a combined stimulation of BALB/c macrophages with IFN-g and
PA. After infection, macrophages were either not treated (M) or treated daily with IFN-g (100 U/ml) (f), PA (2 mM) (E), PA plus IFN-g (F) until day
3 of infection. Each point represents the mean of triplicate determinations 6 SD. Statistically significant growth inhibition is labeled p for p , 0.05,
pp for p , 0.01, and ppp for p 5 0, according to Student’s t test.
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prostaglandin (results not shown). 15d-PGJ2 treatment also pre-
vented the induction of apoptosis in cells treated with PA plus
IFN-g, as evaluated by the maintenance of the ability to reduce
MTT by the mitochondrial respiratory chain (Fig. 6A) or by the
reduction in the exposure of phosphatidylserine (Fig. 6B). The
reduction of apoptosis by 15d-PGJ2 in macrophages treated with
FIGURE 2. Exclusion of several molecules as
mediators of the mycobacteriostatic activity of
PA 6 IFN-g. Bone marrow-derived macrophages
from BALB/c mice were infected with M. avium
strain 25291 SmT and incubated as described in the
previous figure in medium (open bars) or with
IFN-g (light stippled bars), PA (heavy stippled
bars), and PA plus IFN-g (filled bars), in the pres-
ence of iron citrate (5 and 10 mg/ml), apotransferrin
(Tf, 0.5 and 1 mg/ml), and IL-4 (200 and 400 U/ml)
(A), or, in other experiments (B and C), iron sulfate
(5 mg/ml), iron citrate (10 mg/ml), zinc sulfate (10
mg/ml), catalase (0.1 mg/ml), SOD (1500 U/ml), or
anti-TNF (10 mg/ml). In the experiment depicted in
B and C, the iron and zinc salts were added daily, as
were PA and IFN-g. Catalase (0.01 and 0.1 mg/ml)
and SOD (1500 U/ml) were added during and after
phagocytosis. The effects of the different com-
pounds were compared within each incubation
group (controls, IFN-g-treated, PA-treated, or PA 6
IFN-g-treated macrophages) with the respective
control given no compound. Statistically significant
differences are labeled p (p , 0.05) or pp (p ,
0.01), according to Student’s t test.
FIGURE 3. Mycobacteriostasis induced by IFN-g plus PA is independent of NO, TNF-a signaling through p55, or the NADPH oxidase. Bone marrow-
derived macrophages of strains of mice genetically deficient for iNOS, TNFRp55, and NADPH oxidase were tested for anti-M. avium activity induced by
PA 6 IFN-g. Macrophages from C57BL/6 mice were used as controls for all experiments, and similar data were obtained with macrophages from strain
129 (not shown). Statistics as in Fig. 1.
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PA plus IFN-g was associated with a significant increase in the
number of viable bacteria (Fig. 6C). The prostaglandin did not
induce any significant changes in the number of intracellular my-
cobacteria in macrophages treated with PA or IFN-g, or in non-
treated macrophages.
Reactive oxygen intermediate production may lead to pro-
grammed cell death, which can be prevented by the antioxidant
NAC (40–43). We therefore tested the effects of this compound on
both apoptosis and mycobacteriostasis induced by PA. We found
that by adding NAC during phagocytosis (10 mM) and after
phagocytosis (50 mM) during 1 h before treatment with PA of
bone marrow-derived macrophages, we could reduce apoptosis as
measured by exposure of phosphatidylserine at day 4 of treatment
with PA plus IFN-g (Fig. 7A). Furthermore, we completely re-
verted the effect of PA and PA plus IFN-g in the inhibition of M.
avium growth inside the macrophages with the NAC treatment
(Fig. 7B). Addition of glutathione was also effective in reverting
the mycobacteriostatic effect (Fig. 7C).
Discussion
We have shown that PA, a terminal catabolite of tryptophan,
induced anti-M. avium activity in murine macrophages and
synergized with IFN-g, leading to complete mycobacteriostasis.
FIGURE 4. Morphological changes induced by PA are suggestive of apoptosis. Macrophages infected with M. avium 25291 SmT only (A and C) or
treated with PA (B and D) were processed for electron microscopy at day 4 of infection (A and B) or microphotographed in phase contrast at day 6 (C and
D). Magnifications: A, 39,550; B, 37,580; C, 3160; D, 3325.
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All three strains of M. avium tested to date had the same degree of
susceptibility to the mycobacteriostatic effect of PA and PA plus
IFN-g in macrophages, independently of the susceptibility to PA in
axenic medium. Also, the growth of the Gir10 strain was not ar-
rested in axenic media with concentrations of PA up to 32 mM,
whereas this strain was as easily controlled by activated macro-
phages treated with PA as the other two strains of M. avium. These
data strongly argue against a direct effect of PA on mycobacteria,
but suggest an effect mediated through the macrophage.
PA is able to chelate metal ions. However, iron or zinc with-
holding was unlikely the cause of restriction of M. avium growth
inside macrophages treated with PA or PA plus IFN-g. Not only
was the addition of the ion metals ineffective in reverting the bac-
teriostasis, but also the inhibition of the growth of M. avium in-
duced by PA plus IFN-g was higher than the one obtained with
other iron chelators (4). As previously shown by Varesio and co-
workers (34), PA is also a macrophage agonist leading to higher
secretion of cytokines such as TNF-a and of NO. In the system
described in this work, however, TNF-a was not involved in mod-
ulating mycobacterial growth inhibition following PA stimulation,
as either the neutralization of the cytokine with specific mAbs or
the use of bone marrow-derived macrophages from TNF receptor
p552/2 mice failed to have an effect in the macrophages’ anti-M.
avium activity induced by PA or PA plus IFN-g. Finally, neither
oxygen-reactive species generated by the NADPH oxidase nor NO
was mediating growth inhibition after stimulation of macrophages
with PA or PA plus IFN-g. Instead, we have found a new anti-M.
avium macrophage effector mechanism that is concomitant with
the induction of apoptosis and that could only be reverted by
blocking programmed cell death. Others have shown that human
monocytes infected with M. avium and treated with hydrogen per-
oxide enter apoptosis after 6 h with concomitant bacterial killing
(44). Furthermore, bacillus Calmette-Gue´rin and M. tuberculosis
were also killed in human monocytes a few hours after the apo-
ptotic stimulus given by ATP (45, 46) or Fas-L (47). The induction
of apoptosis and mycobacteriostasis in murine macrophages by PA
plus IFN-g had different features from the previously described.
We did not observe bacterial killing, but rather an inability of M.
FIGURE 5. Extensive apoptosis is induced by IFN-g plus PA over an
extended period of days. Infected macrophages were stained with annexin
V-FITC at day 4 of infection (A) or fixed with 70% ethanol and stained
with propidium iodide at day 6 (B) and analyzed by FACS. Macrophages
treated with hydrogen peroxide (10 mM) or killed at 56°C were used as
apoptotic or necrotic controls, respectively.
FIGURE 6. The macrophage deactivator 15d-PGJ2 inhibits both apoptosis and mycobacteriostasis induced by IFN-g plus PA. Infected peritoneal
macrophages treated with PA (days 0, 1, 2, and 3), IFN-g (days 0 and 1), or PA plus IFN-g in the presence of 6 mM 15d-PGJ2 (f) or medium (M) were
assayed for MTT reduction at day 4 of infection (A) or for intracellular viable bacteria (C). The exposure of phosphatidylserine in macrophages treated with
PA plus IFN-g in medium alone (black line) or in the presence of 6 mM 15d-PGJ2 (gray line) was compared by staining with annexin V-FITC (B). The
histograms correspond to cells gated for negative propidium iodide staining. The filled histogram represents nontreated macrophages. Statistics as in Fig.
1.
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avium to grow in treated macrophages. This is more consistent
with what is generally observed in vivo, in which killing of M.
avium is seldom seen and when it occurs it takes place throughout
a protracted period of weeks rather than hours.
While the restriction of M. avium growth was observed from the
early time points of treatment with PA or PA plus IFN-g, apoptotic
changes of the phagocytes were only detected later, starting to
become prominent at day 4 of infection. This suggests that the
mechanism leading to mycobacteriostasis occurs in parallel or is
the same that will result in the programmed cell death pathway,
and that mycobacteriostasis is not a consequence of the late cel-
lular apoptotic changes.
A final argument against a direct role of PA on the inhibition of
M. avium growth inside macrophages comes from the ability to
abolish its effects by preventing apoptosis of the macrophages.
Although the three agents used for that purpose, 15d-PGJ2, NAC,
and glutathione, have pleiotropic effects, their actions are concor-
dant regarding the inhibition of apoptosis, making it less likely that
the effects observed were due to other biological effects shared by
these different molecules. This strongly suggests a link between
the mycobacteriostatic mechanism and that of programmed cell
death. In addition, the bacteriostatic and apoptotic effects of PA
plus IFN-g were closely dependent on the activation of macro-
phages by IFN-g because the mechanism was reverted by the pros-
taglandin 15d-PGJ2 in thioglycolate-elicited macrophages. By
binding to PPAR-g, 15d-PGJ2 has been shown to block expression
of genes mediated by transcription factors associated to inflamma-
tory changes such as AP-1, NF-kB, and Stat1 (38). Although the
known consequence of the activation of PPAR-g in macrophages
is the inhibition of the expression of genes such as those coding for
gelatinase B, TNF-a, and iNOS (38, 39), we observed that another
effect was the inhibition of apoptosis. As a role for TNF-a and NO
in the expression of the PA treatment had been excluded, we feel
that the inhibition of apoptosis is the cause of the abolished anti-M.
avium activity. In addition, whenever we failed to revert the my-
cobacteriostatic effect induced by PA plus IFN-g, e.g., by supply-
ing metal ions, reactive oxygen scavengers, or cytokine modula-
tors, or by using the macrophages from the gene-disrupted mouse
strains, we also failed to detect any differences in the morpholog-
ical alterations described in this work.
The mechanism whereby PA triggers apoptosis is not clarified,
but it could involve the generation of reactive oxygen species or an
alteration of the cytoplasmic redox potential, as suggested by the
results obtained with NAC and glutathione (48, 49). NAC is a thiol
compound that can act either as a hydroxyl radical scavenger or by
increasing the intracellular levels of glutathione, which protects the
cell against oxidative damage. Although the addition of catalase or
catalase plus SOD did not revert the bacteriostatic effect of PA in
our studies, NAC blocked the mycobacteriostasis induced by PA
and PA plus IFN-g probably because of its antiapoptotic effect. A
role for NAC in blocking oxygen-reactive species generated by the
NADPH oxidase with the consequent inhibition of mycobacteri-
ostasis does not seem plausible because no differences were found
when p47phox-deficient mice were compared with wild-type con-
trols. Also, no evidence exists to suggest that oxygen-reactive spe-
cies generated outside the phagosome (e.g., the cytosol or the mi-
tochondria) may lead to mycobacterial growth restriction inside
their vacuolar location. It has been reported that iron (III) picoli-
nate catalyzes the production of hydroxyl radical in the presence of
superoxide radical and hydrogen peroxide (50). Even though the
addition of catalase or SOD plus catalase did not revert PA or PA
plus IFN-g effect, it is possible that the enzymes did not reach the
site in which O22 and H2O2 are formed, presumably intracellular.
A localized production of the hydroxyl radical could initiate lipid
peroxidation and cell damage with subsequent apoptosis (46). On
the other hand, reactive oxygen species also act as second mes-
sengers in the activation of NF-kB (51), a trancription factor that
is associated with transduction of proapoptotic signals in different
cells (52, 53). As 15d-PGJ2 and NAC can inhibit activation of
NF-kB (38, 51, 54), we postulate that activation of NF-kB in mac-
rophages treated with PA and PA plus IFN-g is central for both
apoptosis and induction of mycobacteriostasis.
IFN-g clearly enhanced the apoptotic and bacteriostatic activity
of PA in infected macrophages. That effect is not a combination of
two separate anti-M. avium activities because in thioglycolate-elic-
ited peritoneal macrophages, the activity of PA plus IFN-g was
reverted by 15d-PGJ2 without disturbing the activities of PA alone.
Interestingly, IFN-g is a cytokine that may inhibit cell growth and
FIGURE 7. The inhibitor of apoptosis, NAC, prevents the induction of
mycobacteriostasis by IFN-g plus PA. A, Exposure of phosphatidylserine
was analyzed by staining the cells with annexin V-FITC. Histograms rep-
resent macrophages treated with PA plus IFN-g in medium (black line) or
macrophages that had been with NAC before and during treatment with PA
plus IFN-g (gray line) after gating on cells excluding propidium iodide. B,
Effects of PA or PA plus IFN-g on the growth of M. avium strain 25291
were compared between macrophages cultured in medium (left) and mac-
rophages treated with NAC (right). C, Effects of two different antioxidants
in the inhibition of bacteriostatic activity of PA. M. avium CFU were de-
termined after 6 days of culture with the indicated stimuli in the absence
(M) or presence of NAC (f) or glutathione (p). Statistics as in Fig. 1.
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induce apoptosis (55, 56). Furthermore, a defective Stat1 transcrip-
tion factor in U3 cells inactivated IFN-g signaling and decreased
the constitutive expression of caspases (57). Activation of macro-
phages with IFN- g could prime the cell to the apoptotic effect of
PA. The dissection of the transduction signals involved in this
mechanism could bring important information to the understand-
ing of the antimycobacterial mechanisms.
In summary, we describe a novel pathway of mycobacterial
growth control that is triggered by PA in IFN-g-activated macro-
phages and that is related to changes occurring during the pro-
grammed cell death of the host cell. This pathway does not involve
previously described effector mechanisms such as the respiratory
burst or NO.
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